Skip to content
Sign in
WHO confirms Ebola vaccine trial to begin in DR Congo within weeksAI illustration
StableHealthPolicyScienceReported 2026-10-14 17:20

WHO confirms Ebola vaccine trial to begin in DR Congo within weeks

The World Health Organization announced that the first clinical trial of an Ebola vaccine in the Democratic Republic of Congo is expected to start by the end of October 2026. The trial will test Ervebo, a vaccine approved for the Zaire strain, for potential cross-protection against the Bundibugyo species driving the current outbreak, which has exceeded 9,000 cases and 4,000 deaths.

In depthRead the in-depth story

Why it matters. The trial addresses a critical gap in medical countermeasures for the Bundibugyo Ebola strain, which currently lacks approved vaccines or treatments, and could inform future outbreak responses in Central Africa.

01

Who and what it touches

BelgiumfinancesGenevalocated inUnited Nationspart ofUNHCRpartners withAfricaoperates inaffiliatesservesartificial intelligen…usesBetter Than Cash Alli…member ofWorld Health Or…

Into World Health Organization

From World Health Organization

Each line is a relation with evidence behind it, drawn in the direction it points. A line shows that two things are connected, not how far this change reaches.

02

Evidence

  • MMedical XpressMedia2026-10-14 17:20
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-14 21:45
    View source